top of page

How the secrecy of middlemen inflates drug prices

Most Americans believe drugs cost too much and big pharma is to blame. That powerful political sentiment undergirds Medicare’s new authority to negotiate prices directly with manufacturers. The negotiations may result in lower revenues for pharma but will also imperil future drug development.


Commentaires


bottom of page